Benedetto Vitiello1. 1. Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, Room 7147, 6001 Executive Blvd., MSC 9633, Bethesda, MD 20892-9633, USA. bvitiell@mail.nih.gov
Abstract
RATIONALE: Research in pediatric psychopharmacology has expanded considerably in the last 10 years. Still, controversy remains about the effectiveness and safety of commonly used psychotropics and their role in child treatment, thus pointing to the need for more in-depth and targeted investigations. OBJECTIVES: To review recent accomplishments and current limitations of pediatric psychopharmacology, and discuss approaches to further research. METHODS: Selective review of the relevant literature and research in progress. RESULTS: Controlled clinical trials have been conducted in many common psychiatric disorders in children and adolescents, thus providing a basis on which evidence-based treatment guidelines can be constructed. Little innovation has, however, occurred in treatment development and testing. Safety concerns are prominent and have a major influence on clinical practice and drug utilization. CONCLUSIONS: While a research infrastructure has been successfully built for conducting pediatric clinical trials, important aspects such as long-term treatment effects, optimal sequencing and individualization of interventions, and integration of neuroscience findings into innovative, theory-driven treatment development remain to be addressed.
RATIONALE: Research in pediatric psychopharmacology has expanded considerably in the last 10 years. Still, controversy remains about the effectiveness and safety of commonly used psychotropics and their role in child treatment, thus pointing to the need for more in-depth and targeted investigations. OBJECTIVES: To review recent accomplishments and current limitations of pediatric psychopharmacology, and discuss approaches to further research. METHODS: Selective review of the relevant literature and research in progress. RESULTS: Controlled clinical trials have been conducted in many common psychiatric disorders in children and adolescents, thus providing a basis on which evidence-based treatment guidelines can be constructed. Little innovation has, however, occurred in treatment development and testing. Safety concerns are prominent and have a major influence on clinical practice and drug utilization. CONCLUSIONS: While a research infrastructure has been successfully built for conducting pediatric clinical trials, important aspects such as long-term treatment effects, optimal sequencing and individualization of interventions, and integration of neuroscience findings into innovative, theory-driven treatment development remain to be addressed.
Authors: John S March; Susan G Silva; Scott Compton; Mark Shapiro; Robert Califf; Ranga Krishnan Journal: Am J Psychiatry Date: 2005-05 Impact factor: 18.112
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe Journal: JAMA Date: 2004-08-18 Impact factor: 56.272
Authors: Benedetto Vitiello; Mark A Riddle; Laurence L Greenhill; John S March; Jerome Levine; Russell J Schachar; Howard Abikoff; Julie M Zito; James T McCracken; John T Walkup; Robert L Findling; James Robinson; Thomas B Cooper; Mark Davies; Elena Varipatis; Michael J Labellarte; Lawrence Scahill; Lisa Capasso Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-06 Impact factor: 8.829
Authors: David A Axelson; James M Perel; Boris Birmaher; George R Rudolph; Sharon Nuss; Jeffrey Bridge; David A Brent Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-09 Impact factor: 8.829
Authors: Linda S Brady; Lois Winsky; Wayne Goodman; Mary Ellen Oliveri; Ellen Stover Journal: Neuropsychopharmacology Date: 2008-09-17 Impact factor: 7.853
Authors: Ingeborg M van Geijlswijk; Kristiaan B van der Heijden; A C G Egberts; Hubert P L M Korzilius; Marcel G Smits Journal: Psychopharmacology (Berl) Date: 2010-07-29 Impact factor: 4.530
Authors: Peter M Wehmeier; Ralf W Dittmann; Alexander Schacht; Karin Helsberg; Gerd Lehmkuhl Journal: Child Adolesc Psychiatry Ment Health Date: 2009-02-09 Impact factor: 3.033